240 related articles for article (PubMed ID: 17967980)
1. Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy.
Pawlinski R; Tencati M; Hampton CR; Shishido T; Bullard TA; Casey LM; Andrade-Gordon P; Kotzsch M; Spring D; Luther T; Abe J; Pohlman TH; Verrier ED; Blaxall BC; Mackman N
Circulation; 2007 Nov; 116(20):2298-306. PubMed ID: 17967980
[TBL] [Abstract][Full Text] [Related]
2. Letter by Strande regarding article "Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy".
Strande JL
Circulation; 2008 Jun; 117(24):e495; author reply e496. PubMed ID: 18559709
[No Abstract] [Full Text] [Related]
3. Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis.
Chong SY; Zharkova O; Yatim SMJM; Wang X; Lim XC; Huang C; Tan CY; Jiang J; Ye L; Tan MS; Angeli V; Versteeg HH; Dewerchin M; Carmeliet P; Lam CSP; Chan MY; de Kleijn DPV; Wang JW
Theranostics; 2021; 11(19):9243-9261. PubMed ID: 34646369
[TBL] [Abstract][Full Text] [Related]
4. Protease activated receptor-2 contributes to heart failure.
Antoniak S; Sparkenbaugh EM; Tencati M; Rojas M; Mackman N; Pawlinski R
PLoS One; 2013; 8(11):e81733. PubMed ID: 24312345
[TBL] [Abstract][Full Text] [Related]
5. Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice.
Yokono Y; Hanada K; Narita M; Tatara Y; Kawamura Y; Miura N; Kitayama K; Nakata M; Nozaka M; Kato T; Kudo N; Tsushima M; Toyama Y; Itoh K; Tomita H
J Am Heart Assoc; 2020 Jun; 9(12):e015616. PubMed ID: 32495720
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptors and myocardial infarction.
Antoniak S; Pawlinski R; Mackman N
IUBMB Life; 2011 Jun; 63(6):383-9. PubMed ID: 21438116
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts.
Sonin DL; Wakatsuki T; Routhu KV; Harmann LM; Petersen M; Meyer J; Strande JL
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):460-75. PubMed ID: 23598708
[TBL] [Abstract][Full Text] [Related]
8. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury.
Sevastos J; Kennedy SE; Davis DR; Sam M; Peake PW; Charlesworth JA; Mackman N; Erlich JH
Blood; 2007 Jan; 109(2):577-83. PubMed ID: 16990608
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte-enriched protein CIP protects against pathophysiological stresses and regulates cardiac homeostasis.
Huang ZP; Kataoka M; Chen J; Wu G; Ding J; Nie M; Lin Z; Liu J; Hu X; Ma L; Zhou B; Wakimoto H; Zeng C; Kyselovic J; Deng ZL; Seidman CE; Seidman JG; Pu WT; Wang DZ
J Clin Invest; 2015 Nov; 125(11):4122-34. PubMed ID: 26436652
[TBL] [Abstract][Full Text] [Related]
11. Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Li HL; Zhuo ML; Wang D; Wang AB; Cai H; Sun LH; Yang Q; Huang Y; Wei YS; Liu PP; Liu DP; Liang CC
Circulation; 2007 Apr; 115(14):1885-94. PubMed ID: 17389268
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.
Antoniak S; Rojas M; Spring D; Bullard TA; Verrier ED; Blaxall BC; Mackman N; Pawlinski R
Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2136-42. PubMed ID: 20724699
[TBL] [Abstract][Full Text] [Related]
13. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.
Qian JY; Harding P; Liu Y; Shesely E; Yang XP; LaPointe MC
Hypertension; 2008 Feb; 51(2):560-6. PubMed ID: 18180401
[TBL] [Abstract][Full Text] [Related]
14. Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice.
Yuan Y; Yan L; Wu QQ; Zhou H; Jin YG; Bian ZY; Deng W; Yang Z; Shen DF; Zeng XF; Wang SS; Li H; Tang QZ
Hypertension; 2016 Dec; 68(6):1393-1399. PubMed ID: 27698061
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
[TBL] [Abstract][Full Text] [Related]
16. Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling.
Pillai VB; Sundaresan NR; Kim G; Samant S; Moreno-Vinasco L; Garcia JG; Gupta MP
Am J Physiol Heart Circ Physiol; 2013 Feb; 304(3):H415-26. PubMed ID: 23203961
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
[TBL] [Abstract][Full Text] [Related]
18. Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.
Antoniak S; Cardenas JC; Buczek LJ; Church FC; Mackman N; Pawlinski R
Cardiology; 2017; 136(4):258-268. PubMed ID: 27880950
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
[TBL] [Abstract][Full Text] [Related]
20. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
